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RESUMO – A lepra é uma doença granulomatosa crónica com longo período de incubação causada pelo bacilo Mycobacte-
-rium leprae que afeta principalmente a pele, mucosas e sistema nervoso periférico. Tem risco de sequelas permanentes e im-
pacto significativo na qualidade de vida do paciente. É clinicamente heterogénea com possíveis apresentações atípicas. 
Descrevemos o caso de uma mulher de 31 anos, fototipo V, com lepra multibacilar caracterizada por múltiplos surtos de eri-
tema nodoso leproso como manifestação inaugural. A doença foi adquirida num grupo de crianças e adolescentes de uma 
região endémica de África, evoluiu sem tratamento durante 3 anos, e manifestou-se com algumas características clínicas in-
comuns e notável envolvimento linfático. Destacamos a importância da colaboração entre centros especializados e parcerias 
institucionais, a fim de fornecer os recursos de diagnósti-co e os cuidados adequados às populações afetadas.  
PALAVRAS-CHAVE – Eritema Nodoso; Lepra Lepromatosa; Lepra Multibacilar.
A Case Report of Multibacillary Leprosy Presenting 
with Multiple Outbreaks of Erythema Nodosum 
Leprosum 
ABSTRACT – Leprosy is a chronic granulomatous disease with a long incubation period caused by Mycobacterium leprae that 
mainly affects the skin, mucous membranes and the peripheral nervous system. It carries the risk of per-manent sequels with a 
significant impact on the patient’s quality of life. It has a considerable clinically diver-sity and possible atypical presentations. 
We present a case of a 31-year-old, skin phototype V woman with multibacillary leprosy characterized by multiple outbreaks of 
erythema nodosum leprosum, as an inaugural manifestation of the disease. The disease was acquired within a group of children 
and adolescents from an endemic region of Africa, evolved untreated for 3 years, and presented with unusual features and re-
markable lymphatic involvement. We highlight the importance of building and maintaining collaboration between expert centers 
and institutional partnerships in order to provide the adequate diagnostic resources and appropriate care to the affected popu-
lations.
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INTRODUCTION 
Leprosy is a chronic granulomatous disease with a 
long incubation period caused by Mycobacterium leprae 
that mainly affects the skin, mucous membranes and the 
peripheral nervous system.1-3 It is transmitted from person-
-to-person via inhalation of infectious droplets and has a 
long incubation period.2 Ridley and Jopling leprosy clas-
sification (1966) is based on clinical and histological 
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criteria with two polar forms, from tuberculoid to leproma-
tous, depending upon the cellular immune system of the 
host.4 The operational classification created by the World 
Health Organization (WHO) in order to facilitate the choi-
ce of treatment regimens, clas-sifies leprosy as pauciba-
cillary (characterized by a limited number of skin lesions: 
maximum five) or multi-bacillary (with symmetric skin le-
sions, nodules, plaques and thickened dermis).5,6 We will 
refer to WHO clas-sification throughout the article. Leprosy 
is a serious disease with risk of permanent sequels and a 
significant impact on the patient’s quality of life when not 
promptly treated.3,7-9 It remains one of the leading causes of 
physical disability from an infectious disease in developing 
countries with 1 to 2 million individual disabled because of 
leprosy worldwide.2,10 
We present a patient with multibacillary leprosy acquired 
within a group of children and adolescents from an endemic 
area of Africa that evolved untreated for 3 years and presen-
ted with multiple outbreaks of erythema nodosum leprosum 
(ENL).
CASE REPORT
A 31-year-old female patient, Fitzpatrick skin type V, mis-
sionary, working in Luanda was admitted to our hospital with 
a 3-year history of disseminated skin lesions, fever, malaise, 
anorexia and weight loss (12% of body weight in six mon-
ths). There was no relevant past medical history. The patient 
had first noticed red patches over her feet, 3 years before, 
and these progressively spread to her legs, thighs, arms and 
abdomen. She complained of intermittent pruritus, pain and 
burning sensation on the skin lesions. The symptoms had a 
chronic relapsing-remitting course with multiple outbreaks 
lasting approximately 2 to 3 months. 
Physical examination revealed symmetrically distributed 
red-brown plaques and nodules predominantly on the lower 
extremities (Fig. 1) but also involving the upper extremities 
(Fig. 2) and lower abdomen. A painless left axillary lymph 
node with approximately 2 cm was detected as well as non-
-tender bilateral enlarged and hard inguinal lymph nodes 
(> 2 cm). On the dorsal hands, some of the nodules suppu-
rated spontaneously. The neurological examination was un-
remarkable. Motor evaluation revealed normal muscle bulk 
and tone and strength was normal and symmetric. There 
was no evidence of peripheral sensory loss since light touch, 
pin-prick, position sense, and vibration sense were intact in 
fingers and toes. Reflexes were symmetric (2+) at the biceps, 
triceps, knees, and ankles. No enlarged peripheral nerves 
were palpable. 
Laboratory testing revealed microcytic hypochromic ane-
mia. Serological tests for HCV, HBV, HTLV and HIV types 1 
and 2 were negative. Blood and urine cultures were also 
negative. QuantiFERON testing was positive but the chest 
X-ray did not reveal any stigmata of latent or active tuber-
culosis. A full body computed tomography scan disclosed 
lymph node enlargement in both axillary, inguinal, exter-
nal iliacus and internal obturator areas, and homogeneous 
hepatosplenomegaly, with no focal lesions. Histopathologi-
cal findings on two skin biopsies taken from the most active 
edge of the plaques (from the arm and thigh) were consis-
tent with leprosy (Fig. 3) revealing perivascular lymphohis-
tiocytic aggregates in the dermis. Both isolated bacilli and 
globi (clumps of bacilli) were seen on Ziehl-Neelsen (ZN) 
staining. The aspirate from an inguinal lymph node stained 
with ZN revealed multiple acid-fast bacilli (AFB). Samples for 
bacilloscopy were obtained from the earlobes which allowed 
AFB identification. We were also able to find the bacilli on 
nasal secretions upon mucosal smear examination. A posi-
tive identification for M. leprae was made by nested PCR for 
the detection of RLEP repetitive sequences in a lymph node 
sample. The molecular detection of drug resistance associa-
ted mutations in rpoB, folC and gyrA genes was assessed 
using the GenoType LepraeDR and no mutation was found.
Revista SPDV 77(1) 2019; Lepra multibacilar com surtos de eritema nodoso leproso; R. Bouceiro-Mendes, A. Ortins-Pina, T. Marques, e cols.
Figura 1 - Multibacillary	 leprosy,	clinical	picture:	Symmetrically	dis-
tributed	painful,	red	to	brown	nodules	and	diffusely	infiltrated	plaques.	
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A diagnosis of multibacillary leprosy was made with 
skin, lymph node and spleen involvement. A multi-drug 
therapy with dapsone (100 mg per day), clofazimine (50 
mg per day and 300 mg once a month) and ri-fampicin 
(600 mg per month) for 24 months was proposed. To 
address the associated ENL cochicine (starting with a dose 
of 0.6 mg twice daily) and pentoxifylline (400 mg every 
8 hours) were initially considered (the patient referred a 
history of prednisone allergy). Unfortunately, due to social 
and economic constraints, the patient went back to her 
home country. We were able to contact the patient who let 
us know that she was on the third month of treatment, with 
clinical improvement.
DISCUSSION
Diagnosis of leprosy is based on different clinical para-
meters, mainly on dermatological and neurological exami-
nation. Since M. leprae cannot be grown in vitro, a reliable 
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Figura 2 - Multibacillary	leprosy,	clinical	picture:	Bilateral	hand	edema	with	infiltrated	skin	lesions.
Figura 3 - Multibacillary	leprosy,	histopathological	findings:	(A)	Perivascular	lymphohistiocytic	aggregates	in	the	dermis	(H&E,	x	40).	(B)	Sheets	of	foamy	
histiocytes	with	clumps	(globi)	of	intracellular	AFB	were	identified	on	Ziehl-Neelsen	staining	(x100).
A B
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and definitive diagnosis is obtained by histopathological 
diagnosis and demonstration of AFB in skin biopsies, lymph 
nodes, nasal secretions or skin samples for bacilloscopy 
which are usually collected from the earlobes.1,2 A defini-
tive diagnosis on histo-pathological grounds is not always 
possible. PCR amplification of M. leprae-specific sequen-
ces allows a definitive diagnosis and can be particularly 
useful in cases of paucibacillary leprosy.11-13 In this case, 
the patient had positive skin smears from the earlobes and 
nasal secretions and multiple AFB on the aspirate from an 
involved lymph, consistent with a case of multibacillary le-
prosy hence, molecular techniques were not essen-tial for 
the diagnosis. However, given the unusual presentation 
with notable lymphatic involvement and ab-sence of clini-
cal neurological involvement, PCR positivity of RLEP confir-
med the presence of M. leprae. Beyond routine diagnostic 
tests, sequencing of resistance genes allowed the exclusion 
of strains resistant to rifampicin and dapsone based on the 
most characteristic gene mutations.
Although clinical manifestations of leprosy are largely 
confined to skin and peripheral nervous system, there are a 
few case reports of lepra presenting with lymphadenopathy, 
as in this case.14-16 In fact, leprosy has propensity to involve 
lymph node, spleen, bone marrow, eyes and testes. Singh 
et al. highlight the utility of fine needle aspiration cytology 
(FNAC) in these cases. FNAC of one of the involved lymph 
nodes yields adequate material for cytologic studies.15 Se-
veral other studies and case reports stress out the utility of 
FNAC as an alternative to slit skin smears and skin biop-
sy for diagnosis of all cases of leprosy.17-19 It can be easi-
ly per-formed directly from the skin lesions or ear lobes. 
Studies evaluating the cytomorphology of leprosy lesions in 
FNAC found a histopathological correlation rate of 77% - 
78%.17,19 It may be especially useful in endemic areas where 
histopathological services are not routinely available.
In this case, skin biopsies revealed aggregates of lym-
phocytes and macrophages containing abundant foamy 
cytoplasm. Numerous AFB were seen with ZN staining. 
These features are consistent with a borderline leproma-
tous leprosy, according to Ridley and Jopling classification, 
which correlates well with the clinical picture. In order to 
achieve maximum correlation between clinical and histo-
pathological findings, the selection of the site for biopsy is 
very important since clinically dissimilar lesions from the 
same patient may show different types of histopathology.7,20 
A study from Kumar et al. showed that maximum correla-
tion is seen with lepromatous leprosy.7 We must keep in 
mind that histological findings should always be interpreted 
in correlation with clinical findings.20
This case shows the diversity and possible unusual 
presentations of leprosy, with a complete picture of mul-
tibacillary leprosy but no clinical signs of peripheral nerve 
involvement which cannot be totally excluded since an elec-
troneuromyography was not performed. The clinical evo-
lution is consistent with multiple out-breaks of ENL as a 
manifestation of a non-treated multibacillary lepromatous 
patient. ENL is a type 2 reaction characterized by acute in-
flammation that appears suddenly consisting of an acute 
eruption of symmetrical distributed papules and nodules, 
usually in repeated episodes, lasting several days (usually 
1 to 2 weeks). Patients may exhibit signs of systemic in-
volvement such as fever, lymphadenopathy, limb edema, 
hepatosple-nomegaly, leukocytosis, arthritis, iridocyclitis, 
orchitis, nephritis and painful nerve enlargement, among 
others.1,21-23 It occurs due to the immunological complica-
tions of multibacillary leprosy and it is a systemic inflamma-
tory reaction probably associated with bacterial destruction 
and the release of antigens that leads to antibody produc-
tion and consequent immune-complex formation.21,22 Most 
cases are treated with anti-inflammatory drugs such as ace-
tylsalicylic acid, indomethacin, chloroquine and colchicine. 
Thalidomide has a rapid action, controlling symptoms wi-
thin 24-48 hours. Because of its teratogenicity it should not 
be used as first-line therapy for women in childbearing age. 
Clofazimine, which is included in lepra treatment regimen, 
is effective on chronic ENL. Pentoxifylline is another viable 
option, with a variety of anti-inflammatory effects, but a 
slow action period. Prednisone acts rapidly on the control 
of acute inflammation, but this patient referred an history 
of prednisone allergy.22
Multidrug therapy is warranted to prevent or slow the 
development of resistance. The World Health Organization 
standardized regimen is a three first-line drug combina-
tion, namely, dapsone, rifampicin and clo-fazimine for all 
leprosy patients, with a duration of treatment of 6 months 
for paucibacillary leprosy and of 12 months for multibaci-
llary leprosy.6 However, treatment is difficult since it must be 
continued for a long period with potential adverse effects 
from the several drugs used and with a high cost, particu-
larly for less developed countries.9 Treatment tendency is 
towards shorter and uniform drug treatments.6,24 However, 
in this case, a treatment duration of 24 months was propo-
sed because some studies show an increase in severity of 
ENL when one-year is compared to two-year regimen.25,26
Despite effective treatments the prevalence and inciden-
ce of leprosy have plateaued since 2005 and the number 
of new cases diagnosed with permanent disability remains 
unchanged since 2010 reflecting that transmission has not 
stopped.1,10 Therefore, collaboration between expert cen-
ters and institutional partnerships is vital in order to provide 
the adequate diagnostic resources and appropriate care to 
the affected populations.9
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